-
1
-
-
0024475254
-
Pharmacokinetics and toxicity of continuous infusion of amphotericin B in cancer patients
-
Cabor, G. G., R. Pazdur, F. A. Valeriote, and L. H. H. Baker. 1989. Pharmacokinetics and toxicity of continuous infusion of amphotericin B in cancer patients. J. Pharm. Sci. 78:307-310.
-
(1989)
J. Pharm. Sci.
, vol.78
, pp. 307-310
-
-
Cabor, G.G.1
Pazdur, R.2
Valeriote, F.A.3
Baker, L.H.H.4
-
2
-
-
9444294262
-
Clinical application of therapeutic drug monitoring
-
W. J. Taylor and M. H. Diers Caviness (ed.), Diagnostics Division, Abbott Laboratories, Irving, Tex.
-
Cipolle, R. J., and J. S. Solomkin. 1986. Clinical application of therapeutic drug monitoring, p. 321-328. In W. J. Taylor and M. H. Diers Caviness (ed.), Amphotericin B. Diagnostics Division, Abbott Laboratories, Irving, Tex.
-
(1986)
Amphotericin B
, pp. 321-328
-
-
Cipolle, R.J.1
Solomkin, J.S.2
-
3
-
-
0027167664
-
The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B
-
Feingold, K. R., R. M. Krauss, M. Pang, W. Doerrler, P. Jensen, and C. Grunfield. 1993. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J. Clin. Endocrinol. Metab. 76:1423-1427.
-
(1993)
J. Clin. Endocrinol. Metab.
, vol.76
, pp. 1423-1427
-
-
Feingold, K.R.1
Krauss, R.M.2
Pang, M.3
Doerrler, W.4
Jensen, P.5
Grunfield, C.6
-
4
-
-
0004061014
-
-
Marcel Dekker, Inc., New York
-
Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, p. 1-41. Marcel Dekker, Inc., New York.
-
(1982)
Pharmacokinetics
, pp. 1-41
-
-
Gibaldi, M.1
Perrier, D.2
-
5
-
-
0026716993
-
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
-
Grunfeld, C., M. Pang, W. Doerrler, J. K. Shigenaga, P. Jensen, and K. R. Feingold. 1992. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 74:1045-1052.
-
(1992)
J. Clin. Endocrinol. Metab.
, vol.74
, pp. 1045-1052
-
-
Grunfeld, C.1
Pang, M.2
Doerrler, W.3
Shigenaga, J.K.4
Jensen, P.5
Feingold, K.R.6
-
6
-
-
0002819939
-
Study of lipids and lipoproteins
-
A. M. Scanu and A. A. Spector (ed.), Marcel Dekker, Inc., New York
-
Harmony, J. A. K., A. L. Aleson, and B. M. McCarthy. 1986. Study of lipids and lipoproteins, p. 403-430. In A. M. Scanu and A. A. Spector (ed.), Biochemistry and biology of plasma lipoproteins. Marcel Dekker, Inc., New York.
-
(1986)
Biochemistry and Biology of Plasma Lipoproteins
, pp. 403-430
-
-
Harmony, J.A.K.1
Aleson, A.L.2
McCarthy, B.M.3
-
7
-
-
0001571784
-
Unusual lipid structures selectively reduce the toxicity of amphotericin B
-
Janoff, A. S., L. T. Boni, M. C. Popescu, et al. 1988. Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc. Natl. Acad. Sci. USA 85:6122-6128.
-
(1988)
Proc. Natl. Acad. Sci. USA
, vol.85
, pp. 6122-6128
-
-
Janoff, A.S.1
Boni, L.T.2
Popescu, M.C.3
-
8
-
-
0023804373
-
Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease
-
Laakso, M., and K. Pyorala. 1988. Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease. Atherosclerosis 74:55-63.
-
(1988)
Atherosclerosis
, vol.74
, pp. 55-63
-
-
Laakso, M.1
Pyorala, K.2
-
9
-
-
0024162404
-
Liposomes as carriers of antifungal drugs
-
Lopez-Berestein, G. 1988. Liposomes as carriers of antifungal drugs. Ann. N. Y. Acad. Sci. 544:590-597.
-
(1988)
Ann. N. Y. Acad. Sci.
, vol.544
, pp. 590-597
-
-
Lopez-Berestein, G.1
-
10
-
-
0024468204
-
Treatment of systemic fungal infections with liposomal amphotericin B
-
Lopez-Berestein, G., G. P. Bodey, V. Fainstein, M. Keating, L. S. Frankel, B. Zeluff, L. Gentry, and K. Mehta. 1989. Treatment of systemic fungal infections with liposomal amphotericin B. Arch. Intern. Med. 149:2533-2536.
-
(1989)
Arch. Intern. Med.
, vol.149
, pp. 2533-2536
-
-
Lopez-Berestein, G.1
Bodey, G.P.2
Fainstein, V.3
Keating, M.4
Frankel, L.S.5
Zeluff, B.6
Gentry, L.7
Mehta, K.8
-
11
-
-
0021958862
-
Liposomal-amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study
-
Lopez-Berestein, G., V. Fainstein, R. L. Hopfer, et al. 1985. Liposomal-amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J. Infect. Dis. 154:704-710.
-
(1985)
J. Infect. Dis.
, vol.154
, pp. 704-710
-
-
Lopez-Berestein, G.1
Fainstein, V.2
Hopfer, R.L.3
-
12
-
-
0021268461
-
Liposome-encapsulated amphotericin B for the treatment of disseminated candidiasis in neutropenic mice
-
Lopez-Berestein, G., R. L. Hopfer, R. Mehta, K. Mehta, E. M. Hersh, and R. L. Juliano. 1984. Liposome-encapsulated amphotericin B for the treatment of disseminated candidiasis in neutropenic mice. J. Infect. Dis. 150: 278-283.
-
(1984)
J. Infect. Dis.
, vol.150
, pp. 278-283
-
-
Lopez-Berestein, G.1
Hopfer, R.L.2
Mehta, R.3
Mehta, K.4
Hersh, E.M.5
Juliano, R.L.6
-
13
-
-
0021332795
-
Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B
-
Lopez-Berestein, G., R. L. Hopfer, R. Mehta, K. Mehta, E. M. Hersh, and R. L. Juliano. 1984. Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B. Antimicrob. Agents Chemother. 25:366-367.
-
(1984)
Antimicrob. Agents Chemother.
, vol.25
, pp. 366-367
-
-
Lopez-Berestein, G.1
Hopfer, R.L.2
Mehta, R.3
Mehta, K.4
Hersh, E.M.5
Juliano, R.L.6
-
14
-
-
0020584090
-
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposomal-encapsulated amphotericin B
-
Lopez-Berestein, G., R. Mehta, R. L. Hopfer, K. Mills, L. Kasi, K. Mehta, V. Fainstein, M. Luna, E. M. Hersh, and R. Juliano. 1983. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposomal-encapsulated amphotericin B. J. Infect. Dis. 147:939-945.
-
(1983)
J. Infect. Dis.
, vol.147
, pp. 939-945
-
-
Lopez-Berestein, G.1
Mehta, R.2
Hopfer, R.L.3
Mills, K.4
Kasi, L.5
Mehta, K.6
Fainstein, V.7
Luna, M.8
Hersh, E.M.9
Juliano, R.10
-
15
-
-
0021709937
-
Altered tissue distribution of amphotericin B by liposomal encapsulation; comparison of normal mice to mice infected with Candida albicans
-
Lopez-Berestein, G., M. G. Rosenblum, and R. Mehta. 1984. Altered tissue distribution of amphotericin B by liposomal encapsulation; comparison of normal mice to mice infected with Candida albicans. Cancer Drug Delivery 1:199-205.
-
(1984)
Cancer Drug Delivery
, vol.1
, pp. 199-205
-
-
Lopez-Berestein, G.1
Rosenblum, M.G.2
Mehta, R.3
-
16
-
-
0025786962
-
Attenuation of amphotericin B nephrotoxicity in the candidiasis rat model
-
Luke, D. R., K. M. Wasan, R. R. Verani, L. J. Brunner, K. L. Berens, K. Vadiei, and G. Lopez-Berestein. 1991. Attenuation of amphotericin B nephrotoxicity in the candidiasis rat model. Nephron 59:139-144.
-
(1991)
Nephron
, vol.59
, pp. 139-144
-
-
Luke, D.R.1
Wasan, K.M.2
Verani, R.R.3
Brunner, L.J.4
Berens, K.L.5
Vadiei, K.6
Lopez-Berestein, G.7
-
18
-
-
0028337222
-
Phagocyte transport as a mechanism for enhanced therapeutic activity of liposomal amphotericin B
-
Mehta, R. T., T. J. McQueen, A. Keyhani, and G. Lopez-Berestein. 1994. Phagocyte transport as a mechanism for enhanced therapeutic activity of liposomal amphotericin B. Exp. Chemother. 40:256-264.
-
(1994)
Exp. Chemother.
, vol.40
, pp. 256-264
-
-
Mehta, R.T.1
McQueen, T.J.2
Keyhani, A.3
Lopez-Berestein, G.4
-
19
-
-
0025298008
-
Interaction of lipid transfer protein with plasma lipoproteins and cell membranes
-
Morton, R. E. 1990. Interaction of lipid transfer protein with plasma lipoproteins and cell membranes. Experientia 46:552-560.
-
(1990)
Experientia
, vol.46
, pp. 552-560
-
-
Morton, R.E.1
-
20
-
-
0020573284
-
Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma
-
Morton, R. E., and D. B. Zilversmit. 1983. Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J. Biol. Chem. 258:11751-11757.
-
(1983)
J. Biol. Chem.
, vol.258
, pp. 11751-11757
-
-
Morton, R.E.1
Zilversmit, D.B.2
-
21
-
-
0028321467
-
Amphotericin B use in a major acute care hospital
-
Nicholl, T., P. Phillips, and P. J. Jewesson. 1994. Amphotericin B use in a major acute care hospital. Clin. Ther. 16:28-40.
-
(1994)
Clin. Ther.
, vol.16
, pp. 28-40
-
-
Nicholl, T.1
Phillips, P.2
Jewesson, P.J.3
-
22
-
-
0023906502
-
Adverse effect of amphotericin B administration on renal hemodynamics in the rat neurohumoral mechanisms and influence of calcium channel blocker
-
Tolins, J. P., and L. Raij. 1989. Adverse effect of amphotericin B administration on renal hemodynamics in the rat neurohumoral mechanisms and influence of calcium channel blocker. J. Pharmacol. Exp. Ther. 245:594-599.
-
(1989)
J. Pharmacol. Exp. Ther.
, vol.245
, pp. 594-599
-
-
Tolins, J.P.1
Raij, L.2
-
23
-
-
0025220388
-
Pharmacokinetics of two alternative dosage forms for cyclosporine: Liposomes and intralipid
-
Venkataram, S., W. M. Awni, K. Jordan, and Y. E. Rahman. 1990. Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid. J. Pharm. Sci. 79:216-219.
-
(1990)
J. Pharm. Sci.
, vol.79
, pp. 216-219
-
-
Venkataram, S.1
Awni, W.M.2
Jordan, K.3
Rahman, Y.E.4
-
24
-
-
0027513337
-
Role of liposome composition and temperature on the distribution of amphotericin B in serum lipoproteins
-
Wasan, K. M., G. A. Brazeau, A. Keyhani, A. C. Hayman, and G. Lopez-Berestein. 1993. Role of liposome composition and temperature on the distribution of amphotericin B in serum lipoproteins. Antimicrob. Agents Chemother. 37:246-250.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 246-250
-
-
Wasan, K.M.1
Brazeau, G.A.2
Keyhani, A.3
Hayman, A.C.4
Lopez-Berestein, G.5
-
25
-
-
9444240040
-
Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated low-density cholesterol
-
in press
-
Wasan, K. M., and J. S. Conklin. Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated low-density cholesterol. Clin. Infect. Dis., in press.
-
Clin. Infect. Dis.
-
-
Wasan, K.M.1
Conklin, J.S.2
-
26
-
-
0028136814
-
Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion
-
Wasan, K. M., V. B. Grossie, Jr., and G. Lopez-Berestein. 1994. Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion. Antimicrob. Agents Chemother. 38:2224-2226.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 2224-2226
-
-
Wasan, K.M.1
Grossie Jr., V.B.2
Lopez-Berestein, G.3
-
27
-
-
0027742038
-
The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers
-
Wasan, K. M., and G. Lopez-Berestein. 1993. The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers. Arch. Med. Res. 24:395-401.
-
(1993)
Arch. Med. Res.
, vol.24
, pp. 395-401
-
-
Wasan, K.M.1
Lopez-Berestein, G.2
-
28
-
-
0028306292
-
Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: Role of lipid transfer protein
-
Wasan, K. M., R. E. Morton, M. G. Rosenblum, and G. Lopez-Berestein. 1994. Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein. J. Pharm. Sci. 83:1006-1010.
-
(1994)
J. Pharm. Sci.
, vol.83
, pp. 1006-1010
-
-
Wasan, K.M.1
Morton, R.E.2
Rosenblum, M.G.3
Lopez-Berestein, G.4
-
29
-
-
0028084861
-
Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B
-
Wasan, K. M., M. G. Rosenblum, L. Cheung, and G. Lopez-Berestein. 1994. Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B. Antimicrob. Agents Chemother. 38:223-227.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 223-227
-
-
Wasan, K.M.1
Rosenblum, M.G.2
Cheung, L.3
Lopez-Berestein, G.4
-
30
-
-
0025259879
-
Pharmacokinetics, tissue distribution and toxicity of free and liposomal amphotericin B in a diabetic rat model
-
Wasan, K. M., K. Vadiei, G. Lopez-Berestein, and D. R. Luke, 1990. Pharmacokinetics, tissue distribution and toxicity of free and liposomal amphotericin B in a diabetic rat model. J. Infect. Dis. 161:562-566.
-
(1990)
J. Infect. Dis.
, vol.161
, pp. 562-566
-
-
Wasan, K.M.1
Vadiei, K.2
Lopez-Berestein, G.3
Luke, D.R.4
|